Changes in Beneficial Ownership · 4
Insight Molecular Diagnostics Inc.
IMDXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-11-17
- Issuer
- Insight Molecular Diagnostics Inc.
- Issuer CIK
- 0001642380
- Trading symbol
- IMDX
Reporting owner 1
- Name
- SMITH PATRICK W
- Reporting owner CIK
- 0001167028
- Relationship
- 10% owner
- Address
- C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE, TN, 37217
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | J · Form 4 | 1,142,857[F1] | A | 1.75 | 4,401,342 | I | See Footnote[F2] |
Table key
- J · Form 4
- Other acquisition or disposition; see explanation
- A
- Acquired
- I
- Indirect
Footnotes
- F1
- Reflect shares of Insight Molecular Diagnostics Inc.'s (the "Issuer") common stock, no par value, purchased by the Reporting Person in an underwritten public offering of the Issuer at the public offering price of $1.75.↩ 1
- F2
- The shares of common stock reported herein are directly held by Patrick W Smith The Smith Irrevocable Trust U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.↩ 1
Signature 1
- Signed
- /s/ Patrick W. Smith
- Date
- 2026-11-20